赢8娱乐糖果配对游戏-官方网站[welcome]


+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Closing Remarks H 2 -Receptor Antagonists and Helicobacter pylori Eradication



Closing Remarks H 2 -Receptor Antagonists and Helicobacter pylori Eradication



Scandinavian Journal of Gastroenterology 30(s212): 126-127




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 068447086

Download citation: RISBibTeXText

DOI: 10.3109/00365529509090311


Related references

H2-receptor antagonists an Helicobacter pylori eradication. Scandinavian Journal of Gastroenterology. Supplement 212: 126-127, 1995

Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication. Medical Science Monitor 17(5): Cr235, 2011

Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis. Lancet 347(9003): 763, 1996

Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication. Nihon Rinsho. Japanese Journal of Clinical Medicine 57(1): 153-156, 1999

Meta-analysis: proton pump inhibitors vs. H2-receptor antagonists--their efficacy with antibiotics in Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 18(8): 757-766, 2003

Cost effectiveness of Helicobacter pylori eradication in patients on long-term H2 receptor antagonists A large prospective study in general practice. Gut 48(Suppl. 1): A32, 2001

Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care. Helicobacter 7(2): 91-98, 2002

Gastrointestinal Diseases in the Era without Helicobacter pylori infection. Topics: II. Present Status of Helicobacter pylori Eradication Therapy and Problems after Eradication. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 106(1): 16-22, 2017

The prevalence of Helicobacter pylori infection in patients receiving long-term H-2-receptor antagonists in general practice Clinical and financial consequences of eradication using omeprazole plus amoxycillin or triple therapy. American Journal of Gastroenterology 89(8): 1367, 1994

Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer? Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication. Langenbeck's Archives of Surgery 389(2): 83-91, 2004

Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study. American Journal of the Medical Sciences 338(6): 459-464, 2009

Helicobacter pylori and non-Helicobacter pylori bacterial flora before and after eradication therapy of Helicobacter pylori. Gut 37(Suppl. 1): A14, 1995

Maintenance therapy with H2-receptor antagonist until assessment of Helicobacter pylori eradication can reduce recurrence of peptic ulcer after successful eradication of the organism: prospective randomized controlled trial. Journal of Gastroenterology and Hepatology 21(6): 1048-1053, 2006

Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation Proton Pump Inhibitors for Helicobacter pylori Eradication Therapy. Digestion 97(3): 212-218, 2018

Proton pump inhibitors versus H2 antagonists Meta-analysis of its efficacy with antibiotics on Helicobacter pylori eradication. Gut 51(Suppl. 2): A93-A94, 2002





赢8娱乐糖果配对游戏